Rameda Expands Freely Priced Portfolio with Launch of Ramelact, Egypt’s First Lactase Enzyme Supplement for the treatment of Lactose Intolerance 15:06 28 May in news by ramedahc Read More
Rameda Maintains its Impressive Momentum with the Launch of a New Type 2 Diabetes Product, Bolstering its Chronic Portfolio 15:03 28 November in news by ramedahc Read More
Equinox Pharma Holding Limited (Equinox) increases stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. 15:03 06 November in news by ramedahc Read More
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. finalizes acquisition of a portfolio of 11 fast-growing cardiometabolic products 15:03 01 June in news by ramedahc Read More
Rameda acquires exclusive rights for the distribution and marketing of “Physiomer” in Egypt 15:01 20 December in news by ramedahc Read More
